Clinical Trial Update: Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the combination of gliclazide MR with basal insulin versus insulin alone in type 2 diabetes, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal insulin (basal insulin)
• Gliclazide MR (gliclazide MR)

Snippet

Sponsor: Servier (Tianjin) Pharmaceutical Co. LTD. | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED